The emerging class of GLP-1 agonist medication and GIP co-agonist medications, including tirzepatide, semaglutide, and the relatively introduced retatrutide, provide groundbreaking advances in diabetes https://semaglutide742507.thunkblog.com/940651/semaglutide-the-thorough-look